GNW
Genworth Financial Inc Financials Life Insurance Russell 3000
$8.78Close
$3.4BMarket cap
$7.94 – $10.6052-week range
Nov 4, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Lagging the market RS 39 · weaker than 61% of stocks over 12 months
- Earnings shrinking EPS −0% year on year
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
17%
1wk
down 1.5%
price change
1mo
down 2.1%
price change
12-month return
up 4%
market up 11% ·
its own down 5%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
15.4×
price / earnings
PEG
—
P/E / EPS growth
P/B
0.4×
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
0%
year on year
EPS growth
0%
latest quarter · +6 pts
Sales growth
up 6%
latest quarter · +6 pts
ROE
up 3%
return on equity
Free cash margin
—
D/E
0.17
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Revenue reaccelerating (-3% then +0%)
Trade setup
ATR%
2.8%
$0.25 a day · 2×ATR $8.29
RS
39 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.05
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026-1% vs market2 sessions after results
Financials
- Net 3%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3B | $7.8B | $7.5B | $7.5B | $7.3B | $7.3B |
| Operating income | $310.0M | $474.0M | $818.0M | $41.0M | — | — |
| Net income | $178.0M | $850.0M | $916.0M | $76.0M | $299.0M | $223.0M |
| Net margin | 2% | 11% | 12% | 1% | 4% | 3% |
| Earnings per share | $0.35 | $1.65 | $1.79 | $0.16 | $0.68 | $0.54 |
| Cash | $1.0B | $1.6B | $1.8B | $2.2B | $2.0B | $2.0B |
| Long-term debt | $3.4B | $1.9B | $1.6B | $1.6B | $1.5B | $1.5B |
| Shareholders' equity | $15.3B | $15.5B | $7.6B | $7.5B | $8.4B | $8.8B |
| Shares outstanding | 506m | 508m | 495.45m | 446.82m | 421.42m | 391.84m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 2, 2025 | Quarterly ↗ | Mar 31, 2025 | 32d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 2, 2024 | Quarterly ↗ | Jun 30, 2024 | 33d |
| May 3, 2024 | Quarterly ↗ | Mar 31, 2024 | 33d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 30, 2026 | Director or officer change · Regulation FD ↗ |
| Oct 13, 2026 | Director or officer change ↗ |
| Aug 20, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jul 7, 2026 | Director or officer change ↗ |
| May 21, 2026 | Shareholder vote ↗ |
| May 5, 2026 | Results ↗ |
| Feb 23, 2026 | Results ↗ |
| Feb 3, 2026 | Results ↗ |
| Nov 5, 2025 | Results ↗ |
| Jul 30, 2025 | Results ↗ |
| Jul 18, 2025 | Item 5.04 ↗ |